What it sells
Discovering the true signals of disease to power life-changing drugs.
Business model breakdown
Workflow: what inputs become what output?
Enrolls Newfoundland and Labrador families in a genetics study and pairs genomic data with clinical and family histories to find causal drug targets and biomarkers.
Economics: what it saves and how it charges
Drug discovery: co-develops medicines with life-sciences partners; has a benefits and royalty agreement with the NL government.
Distribution: how it reaches customers
Partnerships with NL Health Services, Memorial University and life sciences industry.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2019 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.